Quick Win By The Algorithm: BCRX On The Rise

Quick Win By The Algorithm: BCRX On The Rise

On March 1, 2017, the I Know First algorithm had predicted a bullish forecast for BioCryst Pharmaceuticals, Inc. (BCRX). BCRX had a signal of 39.22 and a predictability of 0.14. Therefore, in accordance with the Quick Win By the Algorithm, the company reported a gain of 23.08% in just 3 days.

BioCryst Pharmaceutical is a pharmaceutical company that focuses on orphan & autoimmune diseases, and antivirals. BioCryst uses state-of-the-art structure-guided drug design, which incorporates multiple scientific disciplines. This includes biology, crystallography, medicinal chemistry and computer modeling, in order to most efficiently develop new therapeutic candidates.

 

 

On February 28, Donald Trump gave a speech to congress. Trump labeled the U.S. Food and Drug Administrative as “slow and burdensome”. He vowed to slash FDA regulations by 75-80%.  Since his speech, shares of NASDAQ Biotechnology Index ETF and the SPDR S&P Biotech ETF have posted year-to-date gains of 12.97 percent and 19.28 percent, respectively.

BioCryst Pharmaceuticals’ shares jumped 8.16 percent to close at $7.42 a share on Thursday.

BioCryst’s fourth quarter financial statements came out on February 27th. Total revenues increased to $9.0 million from $4.6 million in the fourth quarter of 2016. Also, selling, general and administrative (SG&A) expenses of $2.6 million in the fourth quarter of 2016 decreased slightly from the $2.7 million in the fourth quarter of 2015.

With an increase in total revenue and decrease in expenses, BioCryst Phamaceutical’s reports a positive growing year.

Also on February 27th, the Company reported statistically significant and clinically meaningful results in an ongoing APeX-1 clinical trial in patients with HAE.

This bullish forecast on BCRX was sent to current I Know First subscribers on March 1, 2017. 

Before making any trading decisions, consult the latest forecast as the algorithm constantly updates predictions daily. While the algorithm can be used for intra-day trading the predictability tends to become stronger with forecasts over longer time-horizons such as the 1-month, 3-month and 1-year forecasts.